News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Shire Entertained Many "Large Opportunities" Before AbbVie (ABBV) Bid


6/27/2014 9:14:10 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Shire plc (Nasdaq; SHPG) is said to have pursued a number of deals before disclosure of an approach by AbbVie (NYSE: ABBV).

CEO Flemming Ornskov told the WSJ that AbbVie's offer "stopped us in our tracks."

Ornskov said "there were a number of large opportunities that we were considering, pursuing, preparing for, or engaging in" prior to AbbVie's offer.

Help employers find you! Check out all the jobs and post your resume.


comments powered by Disqus
AbbVie
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES